XML 75 R66.htm IDEA: XBRL DOCUMENT v2.4.1.9
EQUITY INCENTIVE PLAN (Stock Appreciation Rights) (Details) (Stock Appreciation Rights (SARs), USD $)
12 Months Ended
Dec. 31, 2014
Stock Appreciation Rights (SARs)
 
Number of SARs  
Balance at beginning of period (in shares) 138,333us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Granted (in shares) 15,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Forfeited (in shares) (34,788)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Expired (in shares) (20,212)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Balance at end of period (in shares) 98,333us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Exercisable at end of period (in shares) 35,208tbio_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted Average Exercise Price  
Balance at beginning of period (in usd per share) $ 4.32us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Granted (in usd per share) $ 3.15us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Forfeited (in usd per share) $ 4.32us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Expired (in usd per share) $ 4.32tbio_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExpirationsWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Balance at end of period (in usd per share) $ 4.14us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Exercisable at end of period (in usd per share) $ 4.32tbio_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember